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Objective.Toperforma surveyofthe American Society ofRetina Specialists (ASRS)regarding the useofvitreous cavity ﬂuorinated
gas as an adjunct to pars plana vitrectomy for retinal detachment or macular hole repair. Methods. A multiple-choice online ques-
tionnaire was administered to members of ASRS. Physician experience, gas preference for vitrectomy, and categorical estimate of
observation of blinding postoperative ischemic events were recorded. Results. 282 questionnaires were completed. Mean years in
vitreoretinal practice were 15±10. A decrease in yearly vitrectomy volume was associated with increased number of years in prac-
tice (P = 0.011). Greater than 95% of respondents preferred ﬂuorinated gas to air alone for both retinal detachment and macular
hole repair. 38% of respondents reported at least one observation of a blinding ischemic postoperative event. Overall estimated
incidence of blinding postoperative ischemic event was 0.06 events/year in practice. Conclusions. Currently, C3F8 and SF6 are the
postoperative gas preference for ASRS respondents, in contrast to previous North American surveys. The occurrence of blinding
ischemiceventsappearsunrelatedtonumberofyearsinpractice,wasreportedbylessthanhalfofthosesurveyed,andhasoccurred
at an infrequent rate of approximately once for every ten years of practice for those observing the phenomena.
1.Introduction
Retinal detachment (RD) and macular hole (MH) surgery
frequentlyinvolvetheuseofintravitrealgas.Theuseofintra-
vitreal air injection for the repair of retinal detachment (RD)
was ﬁrst described by Ohm in 1911 [1] and later by Rosen-
gran [2].
The subsequent search for an ideal intravitreal gas with
the ability to be injected in small volumes, inert, insoluble
in aqueous media, nontoxic, and have a duration of presence
longer than air lead to the use of sulfur hexaﬂuoride (SF6)
[3], and perﬂuorinated short-chain carbon compounds
(C2F6, C3F8, C4F8, and C4F10) [4, 5]. These compounds
draw dissolved vitreous nitrogen, oxygen, and carbon diox-
ide into the infused bubble at a greater rate than the pas-
sive outward diﬀusion of ﬂuorinated gas, which leads to
expansion of the initial gas volume. 100% C3F8 expands to
four times its initial volume over 96 hours and is present for
approximately 35 days [5–7]. 100% SF6 expands 2–2.5 times
its initial volume over 48 hours and maintains an eﬀective
presence for 7–10 days [5, 6]. High gas surface tension and
buoyancy allow reapposition of the neurosensory retina to
theunderlyingretinalpigmentepitheliumandpreventinﬂux
of additional vitreous ﬂuid into the subretinal space through
retinal breaks.
The use of vitreous cavity ﬂuorinated gases (VCFG),
particularly SF6 and C3F8, have become an integral part
of many scleral buckling (SB) and pars plana vitrectomy
(PPV) procedures [8–11]. Previous investigations regarding
physician preference regarding FG in vitreoretinal surgery
have been reported showing roughly equal distributions of
plain air, SF6, or C3F8 for uncomplicated RD cases and
a trend toward longer-acting FG for increased detachment
complexity [12, 13]. A recent Japanese survey including over2 Journal of Ophthalmology
Table 1: American Society of Retina Specialists survey respondent
characteristics.
Estimated average yearly
vitrectomy volume
{Category—n (%)}
Number of years in practice
<100—45 (16) 19 ± 11∗
100–300—202 (72) 15 ± 10
>300—35 (12) 13 ± 8∗
Overall—282 (100) 15 ± 10
∗Values signiﬁcantly diﬀerent from overall mean (P = 0.013) via one-way
ANOVA, overall values represent 33% ASRS response rate.
150,000 surgeries indicated a preference for SF6 in both RD
and MH cases, with intraocular pressure (IOP) rise being a
common complication (15%). We have observed the occur-
rence of infrequent acute (within 72 hours) postoperative
intraocular pressure elevation and at least two cases of
ischemic optic neuropathy or central retinal artery occlusion
resulting in no light perception following PPV with adjunc-
tive expansile gas. No recent North American study, to our
knowledge, addresses current trends in type of FG, concen-
tration preference, or occurrence of these infrequent VCFG-
related complications. The purpose of the present study was
to survey vitreoretinal specialists regarding their preference
for VCFG as an adjunct to vitreoretinal surgery (PPV or SB)
and their observation of complications potentially associated
with the use of expansile gases, such as IOP elevation and
vascular occlusions or other blinding ischemic events (IE).
2. Methods
The study conformed to the tenets set forth in the Declara-
tion of Helsinki and was exempt from IRB approval. A 12-
item questionnaire (Figure 1) was designed to assess physi-
cian preference for VCFG related to retinal reattachment
procedure, MH repair, number of years in practice, and
history of observation of complications. A list of e-mail
addresses of members of the American Society of Retina
Specialists (ASRS) was obtained from ASRS e-mail directory.
846vitreoretinalspecialistswereavailablefromthedirectory.
A free online survey (Figure 1) was constructed using Survey
Monkey (Palo Alto, CA, USA). Members were petitioned via
email for participation in the survey. Results were tabulated
over a one-month study period from 7/2011–9/2011. IE
was deﬁned either as central retinal artery occlusion, central
retinalveinocclusion,orischemicopticneuropathyresulting
in dramatic permanent decrease in vision occurring within
72 hours of a PPV with VCFG. No physician identifying
information was recorded in the survey or required to par-
ticipate in the web-based survey. Power calculation (alpha =
0.05,sigma=2)wasperformedforallplannedstatisticsprior
to study initiation and indicated a minimum sample size
of 158 responses. Results were tabulated and data analyzed
using JMP 9 (SAS, Cary, NC, USA). Statistical signiﬁcance
was considered present for P<0.05.
(a)
(b)
Figure 1: Online survey completed by American Society of Retina
Specialist Members. 12-item questionnaire regarding postoperative
intravitreal gas preference, vitreoretinal experience, and observa-
tion of rare complications.
3. Results
282participantscompletedthesurvey(33.3%responserate).
Asummaryofrespondentsurgicalvolumeandyearsinprac-
tice is demonstrated in Table 1. Increased number of years
in practice was inversely correlated to vitrectomy volume via
logistic regression (P = 0.0113). There were no signiﬁcant
correlations between VCFG choice for RD repair versus MH
and number of years in practice. VCFG preference by pro-
cedure and gas concentration is demonstrated in Table 2.A
signiﬁcantly larger proportion of respondents reported the
use of SF6 for MH than for RD (P<0.001). There were
no reports of the use of gases other than air, C3F8, or SF6.
Analysis of the subgroup of respondents using air revealed
no signiﬁcant diﬀerence in years of practice experience
(P = 0.431). Regarding intraoperative technique of air-gas
exchange, 90% (n = 239) of respondents used a “full ﬁll”
with an isoexpansile mixture, 9% (n = 25) use injection of
pureVCFGintoanestimatedeyevolumetoachieveadesiredJournal of Ophthalmology 3
Table 2: ASRS member preferred intraocular gas type as adjunct to pars plana vitrectomy procedure∗.
Procedure Air n (%) SF6 n (%) C3F8 n (%)
Retinal detachment 14 (5) 134 (48) 134 (48)
Macular hole 6 (2) 160 (57)† 116 (41)
Gas concentration All 100% 22 ± 9.7 (n = 252) 15 ± 9.4 (n = 262)
∗Responses to online survey, n = 282, ASRS = American Society of Retina Specialists, for gas concentration, mean ± standard deviation of concentrations
reported as continuous variable among n positive respondents for each gas category.
†Signiﬁcantly greater than for retinal detachment via chi2 (P < 0.001).
Table 3: American Society of Retina Specialists survey results for intraocular pressure-related events after pars plana vitrectomy with post-
operative ﬂuorinated gas.
Event Yes
n (%)
No
n (%)
If yes, how many times?
(category = n)
Mean years in Practice∗
(mean ± SD)
Blinding ischemic event (CRAO, ION)
107 (38) 175 (77) 1 = 58 14 ± 4.7∗
2–5 = 40 19 ± 5.3∗
>5 = 91 9 ± 9.9∗
Overall years in practice∗
(mean ± SD) 17 ± 5.6 14 ± 5.1 17 ± 5.6 15 ± 10
Therapeutic paracentesis
217 (62) 65 (23) 1 = 51 12 ± 11†
2–5 = 90 15 ± 10
>5 = 76 22 ± 8.8†
Overall mean years in practice
(mean ± SD) 16 ± 3.8† 12 ± 4.8 17 ± 5.6 15 ± 10
∗No signiﬁcant diﬀerences between means via two sample t- t e s tf o ry e sv e r s u sn o( P = 0.089) or via one way ANOVA for “yes” subgroup (P = 0.161), SD =
standard deviation.
†Signiﬁcantly diﬀerent from “no” via two sample t-test for “yes” versus “no” (P = 0.001), and from overall mean via one-way ANOVA for “yes” subgroup.
concentration, and 1% (n = 3) manually dilute pure gas in a
large syringe.
A summary of IOP-related complication and vitreoreti-
nal specialist experience is demonstrated in Table 3.L o g i s t i c
regression revealed no signiﬁcant correlation between report
of at least one IE and number of years in practice (P =
0.089), but a signiﬁcant positive correlation between num-
ber of years in practice and at least one postoperative ther-
apeutic paracentesis (P<0.001). 4200 cumulative years of
vitreoretinal practice were reported. By calculating the num-
ber of responses within each category as follows: one = 1,
2–5 = 5, >5 = 7 we estimated the total reported cases of
IE as 265. The estimated observed rate of IE per year of
vitreoretinal practice, therefore, was 0.06. Only 38% of res-
pondents, however, reported such events. Among respon-
dents reporting at least one IE, the estimated yearly rate
was 0.15, and there were no signiﬁcant diﬀerence in mean
years in practice among respondent groups. No correlation
was found between technique of gas preparation and either
performance of therapeutic paracentesis (P = 0.622) or
observation of IE (P = 0.318). 36% (n = 60) reported the
perceived cause of postoperative IOP-related complications
as communication error with personnel preparing VCFG
concentration, 8% (n = 13) reported confusion regarding
resultant concentration following syringe dilution, 8% (n =
13) reported under estimation of the vitreous cavity volume
when injecting pure gas, and 48% (n = 82) reported “other/
unsure.”
4. Discussion
The results of the present study indicate that postoperative
intraocular gases currently in use by ASRS members are
predominantly C3F8 and SF6 in isoexpansile mixtures. Air
was infrequently used although unrelated to years of practice
experience.Whileyearsofpracticeexperiencewasnotrelated
to choice of SF6 or C3F8, SF6 was the preferred VCFG for
PPV in MH repair. This likely reﬂects the theoretically less
required VCFG duration for MH compared to RD. For RD
repair, an equal proportion of ASRS members use SF6 and
C3F8.Theseﬁndingsareconsistentwithalargerecentsurvey
of Japanese vitreoretinal specialists, [14]b u td i ﬀer from
previous results [12, 13] that indicated relatively equal distri-
butions of air, C3F8, and SF6 after PPV for uncomplicated
RD and MH. This likely reﬂects the trend in availability,
long term knowledge of outcomes, physician training, and
additional experience with postoperative VCFG over the
past two decades. The vast majority of ASRS members
reported using a “full ﬁll” of “isoexpansile” gas (18% C3F8
or 25% SF6), which is also the preference of the authors.
The majority of remaining respondents reported injecting
a known volume of pure gas into an estimated volume of
vitreous cavity air. While this method may lead to a larger
variation in actual induced postoperative concentration,
and theoretically lead to more postoperative IOP-related
events, we did not observe this relationship. In fact, the
precise resultant concentration of immediate postoperative4 Journal of Ophthalmology
VCFG may be impossible to determine, and commonly used
“isoexpansile” concentrations are actually prone to slight
expansion (18% C3F8 and 20–25% SF6) as true isovolumic
gas-air fractions are actually closer to 12% and 18%, respec-
tively [15, 16]. Considering that resultant postoperative
concentrations rarely exceed 95% of air-gas exchange ﬂush
volumes, [17, 18]t r u ei s o v o l u m i cg a sf r a c t i o n sm a ya c t u a l l y
be approximated in vivo.
Although not a primary goal of the study, our results
indicatethatamongthesurveyedASRSmembers,themajor-
ity of vitreoretinal specialists perform between 100 and 300
PPVseachyear.Interestingly,respondentswithmoreyearsof
vitreoretinal practice had lower average yearly volume. This
may indicate a higher proportion of non-PPV procedures
(such as SB) in older vitreoretinal specialists, the perfor-
mance of less surgery with age, or increased oﬃce time or
focus on medical retinal disease due to decreasing reim-
bursement trends in the United States. Many confounding
variables, particularly voluntary response bias may have
impacted this statistical observation. We did not, however,
ﬁnd any association between surgical volume or experience
on VCFG choice, technique, or incidence of complications.
As expected, dramatic postoperative IOP elevation,
although rare, appears to be a phenomenon observed by
most vitreoretinal surgeons. Nevertheless, up to 40% of res-
pondents failed to report any observation of the need for
therapeuticparacentesisafterPPVwithVCFG.Wecouldnot,
however, ﬁnd any statistical association between technique
or experience with the occasional need for paracentesis. This
observation may be due in part to a potentially wide variety
between methods for treating postoperative IOP elevation,
variation in individual IOP threshold for performing a para-
centesis, diﬀerent timing and method for IOP measurement
aftersurgery,perioperativeuseofantiglaucomamedications,
and several other potential confounding variables. Previous
reports have indicated mixed results regarding postoperative
IOPelevationwithintheﬁrst24hoursfollowingvitreoretinal
surgery, [19, 20] but medical management is required in a
relatively small, 4–30% [19–22] of patients. SB with VCFG
or silicone oil, diabetic RD undergoing SB with silicone
oil, expansion of VCFG, and increased duration of retinal
pathology have been implicated as risk factors for postopera-
tive IOP spike [19–22]. A 1989 prospective study [23]o fo v e r
200 vitrectomy cases identiﬁed concomitant SB, gas expan-
sion, trabecular meshwork obstruction, and simultaneous
lensectomy as potential mechanisms of IOP elevation after
PPV, and reported 11% requiring surgery.
Although IE due to expansion of postoperative gas has
been rarely reported, [24–26] predominantly in association
with postoperative atmospheric pressure decline and anes-
thetic gases, [24, 25, 27]i ti sd i ﬃcult to determine its true
incidence. Based on the current study we estimate that this
observation may occur between one and two times for each
20 years of vitreoretinal practice. Again, many confounding
variables including use of retrobulbar anesthesia, voluntary
response bias, variability in postoperative care, and nuances
of intraoperative air-gas exchange technique make this esti-
mate diﬃcult to assess adequately. The largest contingent
of vitreoretinal surgeons reporting at least one IE reported
being unsure of the underlying cause. A large proportion
(38%) observing IE reported a communication error with a
circulating staﬀ member as the cause of VCFG overﬁll. We
therefore stress the importance of close staﬀ observation and
advocate physician mixing and veriﬁcation of gas concentra-
tion prior to vitreous cavity ﬁlling. We hypothesize that IE
results from mechanical compression of the central retinal
artery and vein during sustained IOP elevation after a full
vitreous cavity ﬁll with expansile gas due to inaccurate per-
centage calculations, or inaccurate volume estimates of eyes
with relatively small vitreous cavity volumes.
We conclude that there appears to be a current preferen-
tial use of VCFG compared to plain air for RD and MH
repair. While techniques for gas preparation diﬀer, two pre-
dominant methods (1) using a “full ﬁll” with “isoexpansile
gas” or (2) injection of a known volume of pure gas into the
estimated vitreous cavity volume) comprise the majority of
currently used methods and do not diﬀer with respect to
potential dramatic postoperative IOP elevation or IE.
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